Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?

Journal of medicinal chemistry - 22 Apr 2010

Oelschlaeger Peter, Ai Ni, Duprez Kevin T, Welsh William J, Toney Jeffrey H

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta-Lactamase Inhibitors
Share to beta-Lactamases
Share to Carbapenems
Share to Databases, Factual

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Design

Share to Drug Resistance, Multiple, Bacterial

Share to Klebsiella pneumoniae

Share to Metalloproteins

Source

Open in PubMed Open full text

Identifiers

PMID: 20121112
DOI: 10.1021/jm9012938
PMCID: PMC2855403

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?PMID 20121112Read ↗

New Carbapenemase Inhibitors: Clearing the Way for the β-LactamsSemantic proximity Read ↗

Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitorsSemantic proximity Read ↗

The Challenges of Carbapenemase-Producing<i>Enterobacteriaceae</i>and Infection Prevention: Protecting Patients in the ChaosSemantic proximity Read ↗

Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive updateSemantic proximity Read ↗

Evolving trends of New Delhi Metallo-betalactamse (NDM) variants: A threat to antimicrobial resistance.Semantic proximity Read ↗

Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase InhibitorsSemantic proximity Read ↗

Structural perspectives on clinical β-lactamase inhibitors: From mechanism to resistance.Semantic proximity Read ↗

Extended-spectrum beta-lactamases: the role of inhibitors in therapy.Semantic proximity Read ↗

Adaptive landscape of the metallo-β-lactamase NDM to emerging β-lactam-based therapiesSemantic proximity Read ↗

First report of emergence of OXA-48 carbapenemase-producing Enterobacteriaceae in Singapore: proactive or reactive infection control strategy?Semantic proximity Read ↗

Current Trends in β-Lactam Based β-Lactamases InhibitorsSemantic proximity Read ↗

Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic optionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.